FilingReader Intelligence

Sinopharm Accord's 2024 profit plunges nearly 60 percent

March 17, 2025 at 05:02 PM UTCBy FilingReader AI

Sinopharm Group Co. Ltd. (HKEX: 1099) announced preliminary financial data for its subsidiary, Sinopharm Accord, revealing a substantial decrease in profitability for the year 2024. Net profit attributable to shareholders of the listed company fell by 59.83% to RMB642 million. Basic earnings per share also decreased by 59.93%.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

HKEX:1099Hong Kong Exchange

News Alerts

Get instant email alerts when Sinopharm publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →